SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-010253
Filing Date
2014-06-12
Accepted
2014-06-12 19:04:15
Documents
1
Period of Report
2014-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1651
  Complete submission text file 0001179110-14-010253.txt   3103
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
ABERCROMBIE GEORGE B (Reporting) CIK: 0001485939 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 14908272